Currently, with the surge in COVID-19 cases, there is an increasing focus on personal hygiene along with the increasing production of medical nonwovens and single-use products such as face masks and gloves. This is further expected to drive the growth of the hospital acquired infection control market in the coming years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years.
[304 Pages Report] The hospital acquired infection control market is projected to reach USD 31.3 billion by 2026 from USD 29.1 billion in 2021, at a CAGR of 1.5% during the forecast period. The growth of the hospital acquired infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19.
The increasing use of E-beam sterilization, reintroduction of ethylene oxide sterilization, and the growing healthcare industry and outsourcing of operation to emerging countries are expected to offer high-growth opportunities for market players during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=204343466
The pandemic has disrupted healthcare systems worldwide, with hospitals being overwhelmed due to the increasing influx of patients. Temporary hospitals are also being set up to deal with the growing number of cases. Hence, the spread of COVID-19 has spurred a surge in demand for HAI services due to the growing cases of HAIs in hospital settings.
With the current COVID-19 pandemic wreaking havoc across the globe, various measures are being taken by companies as well as government bodies to drive market growth. For instance, the FDA has recommended that Sterigenics should reopen its ethylene oxide-based sterilization plant in the US. The plant had been shut due to harmful emissions, which were believed to be carcinogenic.
With the COVID-19 outbreak, there has been an unprecedented global demand for advanced healthcare facilities, services, and infrastructure to treat infected patients. With the considerable rise in the cases of COVID-19 across the globe, the number of patient admissions in hospitals has increased significantly, leading to an increase in the demand for disinfection and sterilization measures.
With the prevalence of many epidemics and pandemics around the world, the government bodies of numerous countries are ramping up their healthcare infrastructure to tackle any outbreak. Better reimbursement policies for every citizen to get good healthcare facilities are also helping more people get treatment in hospitals. This aspect eventually boosts the growth prospects of the hospital acquired infection control market.
Furthermore, the COVID-19 pandemic has affected the hospital sector more than any other end user segment. According to a survey conducted by the US Department of Health and Human Services (between March 23 and March 27, 2020), hospitals in the US reported a shortage of specialized providers needed to meet the anticipated patient surge. It also raised concerns that staff exposure to the virus may exacerbate staffing shortages and work overload.
The increasing number of temporary hospitals, the growing need for remote care, and the rising influx of COVID-19 patients have resulted in the expansion of healthcare infrastructure and driven the demand for efficient hospital acquired infection control market products and services.